Article thumbnail

Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design

By Yeong Rhee and Ardith Brunt
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2009). A: Flaxseed lignan increased red blood cell glucose uptake. The Open Nutraceuticals J
  2. (2006). A: Flaxseed supplementation was effective in lowering serum glucose and triacylglycerol in glucose intolerant people. JANA
  3. (2002). A: Pathways from obesity to diabetes.
  4. (1993). Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science
  5. (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance.
  6. (2005). Al-Saleh E, Al-Mulla F: Oxidative stress-mediated alterations in glucose dynamics in a genetic animal model of type II diabetes. Life Sci
  7. (2004). Aljada A, Bandyopadhyay A: Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol
  8. (2000). Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone.
  9. Assessment Tools and Analysis Services.
  10. (2006). Aukema H: Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender. Lipids
  11. (1998). Bashan N: Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes
  12. Body fat distribution.
  13. (2005). Cammer A, Whiting S: Effects of flaxseed fiber on laxation and glycemic response in healthy volunteers.
  14. (2009). Christofidou-Solomidou M: Dietary flaxseed prevents radiation-induced oxidative lung damage, inflammation and fibrosis in a mouse model of thoracic radiation injury. Cancer Biol Ther
  15. (2003). Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes
  16. (2004). Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes.
  17. (2006). Chung N: Relationship between insulin resistance and lipid peroxidation and antioxidant vitamins in hypercholesterolemic patients. Ann Nutr Metab
  18. (2006). Colette C: Activation of oxidative stress by acute glucose fluctuations compared With sustained chronic hyperglycemia in patients With type 2 diabetes. JAMA
  19. (2008). Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemiareperfusion injury. Am J Physiol Lung Cell Mol Physiol
  20. (2007). Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol
  21. (2003). Dietary flaxseed meal reduces proteinuria and ameliorates nephropathy in an animal model of type II diabetes mellitus. Kidney Int
  22. (2005). Dunger D: Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia
  23. (2007). ES: AAPH-mediated antioxidant reactions of secoisolariciresinol and SDG. Org Biomol Chem
  24. (2006). ES: Reactive oxygen species have a causal role in multiple forms of insulin resistance.
  25. (2005). F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation
  26. (2008). Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial.
  27. (2008). Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice.
  28. (2008). Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition
  29. (2009). García-Fuentes E: Oxidative stress in severely obese persons is greater in those with insulin resistance. Obesity
  30. (2003). H: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.
  31. (1997). Hotamisligil G: Protection from obesityinduced insulin resistance in mice lacking TNF-alpha function. Nature
  32. (1997). Hydroxyl radical-scavenging property of secoisolariciresinol diglucoside (SDG) isolated fromflax-seed. Mol Cell Biochem
  33. (2004). I: Increased oxidative stress in obesity and its impact on metabolic syndrome.
  34. (2002). Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes
  35. (1996). Klip A: Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes
  36. (1999). L: Antioxidant activity of the flaxseed lignan secoisolariciresinol diglucoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem
  37. (2005). Long-term effectiveness of weight-loss interventions in adults with prediabetes: a review. Am J Prev Med
  38. (1999). LR: Prevalence and trends in obesity among US adults,
  39. (1999). Mechanisms of TNF-α induced insulin resistance. Exp Clin Endocrinol Diabetes
  40. (2008). Modulation of C-reactive protein, tumor necrosis factor-alpha, and adiponectin by diet, exercise, and weight loss.
  41. (2006). Ockene I: Assocation between dietary fiber and serum C-reactive protein.
  42. Oral Glucose Tolerance Test.
  43. (2005). PE: The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species.
  44. (2009). Protective role of flax lignans against lead acetate induced oxidative damage and hyperlipidemia in rats. Food Chem Toxicol
  45. (1994). Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α.
  46. (2004). Serum tumor necrosis factor-α levels and components of the metabolic syndrome in obese adolescents. Metabolism
  47. (2008). Song W: Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in U.S.
  48. (2008). Sun S: Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects.
  49. (2008). The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr Metab Cardiovasc Dis
  50. (1996). The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil.
  51. (2003). Vinicor F: Markers of inflammation and cardiovascular disease. Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation
  52. (2006). Vitamin E protects the insulin sensitivity and redox balance in rat L6 muscle cells exposed to oxidative stress. Clin Chim Acta
  53. (2005). Wierusz-Wysocka B: Type 2 diabetes mellitus as inflammatory disease. Diabetes Res Clin Pract
  54. (2007). X: Effects of a flaxseed-derived lignan supplement in type 2 diabetic patients: a randomized, double-blind, cross-over trial. PLoS One
  55. (2009). X: Effects of a flaxseed-derived lignan supplement on Creactive protein, IL-6 and retinol-binding protein 4 in type 2 diabetic patients.
  56. (2005). Zampelas A: Apolipoprotein E genotype in dyslipidemic patients and response of blood lipids and inflammatory markers to alpha-linolenic acid. Angiology